Status:

COMPLETED

Alleviation of Common Cold Symptoms

Lead Sponsor:

Applied Biological Laboratories Inc

Collaborating Sponsors:

Econometrica, Inc.

Conditions:

Common Cold

Pharyngitis

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

Upper respiratory infections (URIs) have long posed a significant burden to the US healthcare system. Well before the coronavirus disease of 2019 (COVID-19) pandemic they have been among the most comm...

Eligibility Criteria

Inclusion

  • Otherwise healthy adults with cold symptoms including sore throat who do not meet any of the exclusion criteria listed below,
  • who rate their sore throat at least a 3 on a 10-point scale,
  • who have had a sore throat for less than 48 hours by the time they complete the intake clinical trial manager (CTM) assessment.

Exclusion

  • Sore throat for more than 2 full days at the time of intake CTM assessment
  • Fever or development of fever during the course of the trial
  • Positive COVID-19 test or influenza test at clinical trial administrator (CTA) visit
  • Likelihood of strep throat (to be determined by physician PI to the best of their ability)
  • Less than 2 doses of the coronavirus (COVID-19) vaccine
  • Any allergies to eggs, milk, or aspirin
  • Females who are pregnant or test positive for pregnancy at the CTA visit
  • Any chronic disease such as asthma, hypertension, post-nasal drip, gastroesophageal reflux disease (GERD), cardiopulmonary obstructive disorder (COPD), diabetes, cancer, HIV
  • Any history of allergy in the last 14 days for which they took medication
  • Anyone with fever above 101 or who has taken medication other than birth control in the last 30 days
  • Anyone taking an Angiotensin Converting Enzyme (ACE) inhibitor
  • Participation in another clinical trial within the last 6 months or during this trial
  • Anyone who smokes

Key Trial Info

Start Date :

May 25 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 16 2023

Estimated Enrollment :

157 Patients enrolled

Trial Details

Trial ID

NCT06106880

Start Date

May 25 2022

End Date

June 16 2023

Last Update

January 16 2024

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Telemedicine and Home Visit

Irvine, California, United States, 92614-0120

2

Telemedicine and Home Visit

Washington D.C., District of Columbia, United States, 20016

3

Telemedicine and Home Visit

Atlanta, Georgia, United States, 30002-0082

4

Telemedicine and Home Visit

Baltimore, Maryland, United States, 21215